TDC
TTPH

Thompson Davis & Co’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Thompson Davis & Co’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-191
Closed -$38K – 1211
2015
Q4 		$38K Hold
191
– – 0.05% 306
2015
Q3 		$29K Hold
191
– – 0.04% 368
2015
Q2 		$181K Hold
191
– – 0.21% 106
2015
Q1 		$140K Buy
+191
New +$143K 0.17% 124

Other funds holding TTPH

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Thompson Davis & Co's TTPH Position: Q1 2016 in Review

Thompson Davis & Co sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016, closing a stake of 191 shares — an estimated $38K sold.

Thompson Davis & Co first reported a position in TTPH in Q1 2015 and held it in 4 quarters. The position peaked at $181K in Q2 2015. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

  • Thompson Davis & Co reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 191 Tetraphase Pharmaceuticals, Inc. shares in Q1 2016, an estimated $38K.
  • Thompson Davis & Co first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
  • Thompson Davis & Co's Tetraphase Pharmaceuticals, Inc. position peaked at $181K in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on Thompson Davis & Co's 13F filing for Q1 2016, filed 2 May 2016.